Yigit
Hava Yigit, Ebersbach DE
Patent application number | Description | Published |
---|---|---|
20080258568 | Electrical Linear Drive Device - An electrical linear drive device with an electric linear motor held in a base housing is proposed that has a long-coil system arranged in a motor housing, and a substantially shorter armature that drives a drive element linearly via a drive rod extending to the outside. Two guide rods running in base housing, and a position measuring rod cooperating with at least one position sensor for position detection that plunges, depending on its position, into base housing are connected to drive element. | 10-23-2008 |
Mehment Yigit, Malden, MD US
Patent application number | Description | Published |
---|---|---|
20120004531 | Innately Multimodal Nanoparticles - A gold-coated iron oxide nanoparticle, method of making thereof, and method of using thereof is disclosed. The nanoparticle is substantially toxin free (making it clinically applicable), easily functionalized, and can serve as a contrast agent for a number of imaging techniques, including imaging a subject in at least two distinct imaging modes. Further, the nanoparticle is well-suited for therapeutic uses. | 01-05-2012 |
Mehmet V. Yigit, Delmar, NY US
Patent application number | Description | Published |
---|---|---|
20140370009 | THERAPEUTIC NANOPARTICLES AND METHODS OF USE THEREOF - Provided herein are therapeutic nanoparticles having a diameter of between 10 nm to 30 nm, and containing a polymer coating, and a nucleic acid containing a sequence complementary to a sequence within a micro-RNA identified as having a role in cancer cell metastasis or anti-apoptotic activity in a cancer cell (e.g., miR-10b) or a sequence within an mRNA encoding a pro-apoptotic protein that is covalently linked to the nanoparticle. Also provided are pharmaceutical compositions containing these therapeutic nanoparticles. Also provided herein are methods of decreasing cancer cell invasion or metastasis in a subject having a cancer and methods of treating a metastatic cancer in a lymph node in a subject that require the administration of these therapeutic nanoparticles to a subject. | 12-18-2014 |
Mehmet V. Yigit, Malden, MA US
Patent application number | Description | Published |
---|---|---|
20140241996 | THERAPEUTIC NANOPARTICLES AND METHODS OF USE THEREOF - Provided herein are therapeutic nanoparticles having a diameter of between 10 nm to 30 nm, and containing a polymer coating, and a nucleic acid containing a sequence complementary to a sequence within a micro-RNA identified as having a role in cancer cell metastasis or anti-apoptotic activity in a cancer cell (e.g., miR-10b) or a sequence within an mRNA encoding a pro-apoptotic protein that is covalently linked to the nanoparticle. Also provided are pharmaceutical compositions containing these therapeutic nanoparticles. Also provided herein are methods of decreasing cancer cell invasion or metastasis in a subject having a cancer and methods of treating a metastatic cancer in a lymph node in a subject that require the administration of these therapeutic nanoparticles to a subject. | 08-28-2014 |
Mehmet Veysel Yigit, Urbana, IL US
Patent application number | Description | Published |
---|---|---|
20100166842 | AMPHIPHILIC SUBSTANCES AND FUNCTIONALIZED LIPID VESICLES INCLUDING THE SAME - An amphiphilic substance includes a hydrophobic group, and a polynucleotide group attached to the hydrophobic group. The polynucleotide group includes a first polynucleotide segment and a second polynucleotide segment. The first and second polynucleotide segments are at least partially complementary and are bound together by interactions including base pairing. At least one of the first and second segments includes at least one of an aptamer and a nucleic acid-based enzyme. A lipid vesicle may include the amphiphilic substance, a first polar lipid that is an unstable vesicle former, and a polar liquid. Upon exposure to a rupture agent, the vesicle may rupture, releasing the contents of the vesicle. Substances that may be released from the vesicle include bioactive agents, such as drug agents. | 07-01-2010 |
20140024818 | ALIGNMENT OF NANOMATERIALS AND MICROMATERIALS - The present invention provides a method for preparing a nanoassembly that includes the step of reacting the assembly template with at least one nanomaterial to form the nanoassembly using a bifunctional linker. | 01-23-2014 |
Mehmet Veysel Yigit, Malden, MA US
Patent application number | Description | Published |
---|---|---|
20090098550 | MRI CONTRAST AGENTS AND HIGH-THROUGHPUT SCREENING BY MRI - The present invention provides an MRI contrast agent, comprising: MRI contrast agent particles, and oligonucleotides, attached to the particles. | 04-16-2009 |
Tamer Yigit, Sydney AU
Patent application number | Description | Published |
---|---|---|
20110099073 | Systems and methods for electronic transaction management - Described herein are systems and methods for managing transaction records. In overview, consumers are issued respective tokens, which are presented to a supplier at the time an item is purchased. Rather than, or in addition to, issuing a paper receipt, the point of sale (POS) equipment scans the card and extracts an identifier. The point of sale equipment then formats an electronic receipt and sends the receipt to a predetermined location based on the extracted identifier. | 04-28-2011 |
Ugur Yigit, Istanbul TR
Patent application number | Description | Published |
---|---|---|
20140079219 | SYSTEM AND A METHOD ENABLING SECURE TRANSMISSION OF SMS - The present invention relates to a system ( | 03-20-2014 |